Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gustafson

Showing results (601-610 of 634) with videos related to

Pageof 64
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
A phase I and pharmacokinetic study of exisulind and docetaxel in patients with advanced solid tumorsSamir E Witta, Daniel L Gustafson, A Scott Pierson, et al.
Journal of Viral Hepatitis|November 20, 2018
Dynamic changes in innate immune responses during direct-acting antiviral therapy for HCV infectionJacinta A Holmes, Charles Carlton-Smith, Arthur Y Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
A phase I biological and pharmacologic study of the heparanase inhibitor PI-88 in patients with advanced solid tumorsMichele Basche, Daniel L Gustafson, Scott N Holden, et al.
PPAR Research|May 7, 2010
Kinetic assessment and therapeutic modulation of metabolic and inflammatory profiles in mice on a high-fat and cholesterol dietLaura W Engstrom, Loretta Bober, Shu-Cheng Chen, et al.
Science Advances|May 7, 2025
EYA3 regulation of NF-κB and CCL2 suppresses cytotoxic NK cells in the premetastatic niche to promote TNBC metastasisSheera R Rosenbaum, Connor J Hughes, Kaiah M Fields, et al.
Cell Reports|February 2, 2022
SIX1 reprograms myogenic transcription factors to maintain the rhabdomyosarcoma undifferentiated stateJessica Y Hsu, Etienne P Danis, Stephanie Nance, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 22, 2001
Cloning and characterization of a novel human histamine receptorK L Morse, J Behan, T M Laz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2021
A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695)Thomas W Flaig, Catherine M Tangen, Siamak Daneshmand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2010
Phase I safety, pharmacokinetic, and pharmacodynamic study of ENMD-2076, a novel angiogenic and Aurora kinase inhibitor, in patients with advanced solid tumorsJennifer R Diamond, Bruno R Bastos, Ryan J Hansen, et al.
Journal of Cellular Physiology|March 25, 2010
Proprotein convertase subtilisin/kexin type 9 (PCSK9) affects gene expression pathways beyond cholesterol metabolism in liver cellsHong Lan, Ling Pang, Marsha M Smith, et al.
Pageof 64

Showing results (601-610 of 634) with videos related to

Sort By:
Pageof 64
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
A phase I and pharmacokinetic study of exisulind and docetaxel in patients with advanced solid tumorsSamir E Witta, Daniel L Gustafson, A Scott Pierson, et al.
Journal of Viral Hepatitis|November 20, 2018
Dynamic changes in innate immune responses during direct-acting antiviral therapy for HCV infectionJacinta A Holmes, Charles Carlton-Smith, Arthur Y Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
A phase I biological and pharmacologic study of the heparanase inhibitor PI-88 in patients with advanced solid tumorsMichele Basche, Daniel L Gustafson, Scott N Holden, et al.
PPAR Research|May 7, 2010
Kinetic assessment and therapeutic modulation of metabolic and inflammatory profiles in mice on a high-fat and cholesterol dietLaura W Engstrom, Loretta Bober, Shu-Cheng Chen, et al.
Science Advances|May 7, 2025
EYA3 regulation of NF-κB and CCL2 suppresses cytotoxic NK cells in the premetastatic niche to promote TNBC metastasisSheera R Rosenbaum, Connor J Hughes, Kaiah M Fields, et al.
Cell Reports|February 2, 2022
SIX1 reprograms myogenic transcription factors to maintain the rhabdomyosarcoma undifferentiated stateJessica Y Hsu, Etienne P Danis, Stephanie Nance, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 22, 2001
Cloning and characterization of a novel human histamine receptorK L Morse, J Behan, T M Laz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2021
A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695)Thomas W Flaig, Catherine M Tangen, Siamak Daneshmand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2010
Phase I safety, pharmacokinetic, and pharmacodynamic study of ENMD-2076, a novel angiogenic and Aurora kinase inhibitor, in patients with advanced solid tumorsJennifer R Diamond, Bruno R Bastos, Ryan J Hansen, et al.
Journal of Cellular Physiology|March 25, 2010
Proprotein convertase subtilisin/kexin type 9 (PCSK9) affects gene expression pathways beyond cholesterol metabolism in liver cellsHong Lan, Ling Pang, Marsha M Smith, et al.
Pageof 64